DTGRX | SCMIX | DTGRX / SCMIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 23 years | - |
Gain YTD | 23.509 | 16.456 | 143% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 402M | 14.5B | 3% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 23.90 | 16.14 | 148% |
Returns for 3 years | 5.44 | 4.04 | 135% |
Returns for 5 years | 58.51 | 70.90 | 83% |
Returns for 10 years | 54.48 | 153.31 | 36% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.24 | 0.26 | +0.98% |
First Trust Nasdaq Pharmaceuticals ETF | |||
TACK | 27.74 | 0.11 | +0.39% |
Fairlead Tactical Sector | |||
FLOT | 50.82 | 0.02 | +0.04% |
iShares Floating Rate Bond ETF | |||
LGLV | 165.92 | -0.08 | -0.05% |
SPDR® SSGA US Large Cap Low Volatil ETF | |||
GEMD | 40.15 | -0.13 | -0.31% |
Goldman Sachs Access Emrg Mkts USD BdETF |